PLRX
Pliant Therapeutics Inc
1.00$
+1.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -49.3% | -87.6% | +33.7% | -7.2% | -51.3% | -17.7% | -10.0% | +24.2% | -37.5% | +299.4% | -70.3% | +32.6% | -32.2% | -81.4% | -2,051.6% | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +421.8% | -66.5% | +28.6% | +14.6% | +2.2% | +0.8% | +4.1% | -5.3% | -55.6% | +10.6% | +21.2% | -14.5% | +113.3% | -60.5% | -0.2% | – | – | -27.7% | – | – | |
| – | – | – | – | – | -49.3% | -87.6% | +33.7% | -7.2% | -51.3% | -17.7% | -10.0% | +24.2% | -37.5% | +299.4% | -70.3% | -38.5% | -70.3% | -415.9% | – | – | -111.7% | – | – | – | -139.5% | – | – | – | – | – | – | |
| – | +134.1% | +11.5% | -17.7% | +8.8% | +18.7% | +26.0% | -3.7% | +5.7% | +3.8% | +3.7% | +9.5% | -10.9% | +11.4% | +26.1% | -6.6% | -2.2% | +17.3% | +13.1% | +1.4% | +2.6% | +10.4% | +22.8% | +6.1% | -18.8% | +12.0% | -25.9% | -44.3% | -13.1% | -14.5% | +25.6% | – | |
| – | +115.0% | +1.6% | -2.3% | +20.1% | +29.3% | -24.2% | +51.0% | +22.6% | +16.7% | -16.6% | +40.1% | +2.3% | +9.3% | -3.3% | +6.4% | +61.5% | -0.7% | +3.0% | +5.3% | -9.7% | +10.0% | -1.5% | -5.1% | +1.9% | +6.7% | -13.6% | -22.9% | -25.5% | +6.4% | -12.9% | – | |
| – | +130.0% | +9.7% | -15.1% | +11.0% | +20.9% | +14.8% | +4.4% | +9.3% | +6.9% | -1.6% | +16.3% | -7.4% | +10.8% | +17.6% | -3.5% | +14.6% | +10.6% | +9.7% | +2.6% | -1.4% | +10.3% | +15.7% | +3.3% | -14.0% | +10.5% | -23.4% | -37.4% | -16.6% | -8.8% | +10.9% | – | |
| – | – | – | – | – | -73.9% | -254.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +15.9% | -6.8% | +300.0% | -59.2% | +55.9% | +74.0% | +5.3% | -1.9% | +2.6% | -0.6% | +1.3% | +38.6% | +95.1% | +1.0% | -4.9% | -4.2% | +1.3% | +0.7% | -83.3% | +1,173.5% | -100.0% | – | |
| – | – | – | – | – | -73.8% | -254.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -135.5% | – | – | – | – | – | – | – | – | – | – | – | -181.6% | – | -1,090.3% | – | – | – | -106.9% | – | -86.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -72.4% | -254.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -73.4% | -247.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.